The earnings call presented a mix of strong revenue growth, strategic collaborations, and improved financial guidance, offset by challenges in margins due to tariffs and slower recovery in China. The company's strategic initiatives and product innovations provide a positive long-term outlook.

Company Guidance

During the GE HealthCare Second Quarter 2025 Earnings Call, the company provided an optimistic outlook despite mixed macroeconomic conditions. They reported a revenue of $5 billion for the quarter, reflecting an organic growth of 2% at the high end of their expected range, with service revenue increasing by 7% and product revenue by 2%. The backlog reached a record $21.3 billion, up by $2.2 billion year-over-year. The adjusted EBIT margin was 14.6%, impacted by tariff expenses but partially offset by productivity improvements. The company raised its full-year 2025 guidance, expecting organic revenue growth to approximately 3% and adjusted EPS between $4.43 and $4.63. They anticipate a stronger fourth quarter, with organic revenue growth of 3% to 4%, supported by a robust capital environment and strong backlog conversion. Adjusted gross margin in the second quarter declined 180 basis points year-over-year due to tariffs and new product investments. The company is actively implementing tariff mitigation actions and is focused on delivering new product introductions that have generated over 50% of their sales, demonstrating the success of R&D investments.

Strong Revenue Growth

GE HealthCare reported revenues of $5 billion in the quarter with organic growth of 2%, at the high end of their expected range.

Record Backlog and Book-to-Bill

The company exited the quarter with a record backlog of $21.3 billion, up $2.2 billion year-over-year, and a strong book-to-bill ratio of 1.07x.

Strategic Collaborations

GE HealthCare secured their largest order ever of Omni Legend PET/CT systems in the U.S. and entered strategic collaborations, including a $90 million deal with Ascension and a $250 million collaboration in Europe.

EPS and Free Cash Flow Growth

The company delivered strong adjusted EPS of $1.06 per share, up 6% year-over-year, and free cash flow of $7 million, up $189 million versus the prior year.

R&D Investments and New Product Success

New product introductions generated over 50% of sales, demonstrating success of R&D investments.

Improved Guidance

The company raised its full-year 2025 organic revenue growth guidance to approximately 3% and adjusted EPS guidance to between $4.43 and $4.63.

GE Healthcare Technologies Inc (GEHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

GEHC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 29, 2025	2025 (Q3)	1.05 / -	1.14	―	―	―
Jul 30, 2025	2025 (Q2)	0.92 / 1.06	1	6.00% (+0.06)
Apr 30, 2025	2025 (Q1)	0.91 / 1.01	0.9	12.22% (+0.11)
Feb 13, 2025	2024 (Q4)	1.26 / 1.45	1.18	22.88% (+0.27)
Oct 30, 2024	2024 (Q3)	1.05 / 1.14	0.99	15.15% (+0.15)
Jul 31, 2024	2024 (Q2)	0.98 / 1.00	0.92	8.70% (+0.08)
Apr 30, 2024	2024 (Q1)	0.91 / 0.90	0.85	5.88% (+0.05)
Feb 06, 2024	2023 (Q4)	1.07 / 1.18	1.31	-9.92% (-0.13)
Oct 31, 2023	2023 (Q3)	0.90 / 0.99	0.88	12.50% (+0.11)
Jul 25, 2023	2023 (Q2)	0.87 / 0.92	1.068	-13.86% (-0.15)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

GEHC Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 30, 2025	$77.72	$71.64	-7.82%
Apr 30, 2025	$68.06	$70.30	+3.29%
Feb 13, 2025	$85.82	$93.39	+8.82%
Oct 30, 2024	$85.15	$87.08	+2.27%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does GE Healthcare Technologies Inc (GEHC) report earnings?

GE Healthcare Technologies Inc (GEHC) is schdueled to report earning on Oct 29, 2025, Before Open (Confirmed).

What is GE Healthcare Technologies Inc (GEHC) earnings time?

GE Healthcare Technologies Inc (GEHC) earnings time is at Oct 29, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is GEHC EPS forecast?

GEHC EPS forecast for the fiscal quarter 2025 (Q3) is 1.06.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing